MEDICAMEQ

MEDICAMEN BIOTECH

Small Cap BSE: 531146 NSE: MEDICAMEQ
₹841.8
9.4 (1.13%)
As on 07 December, 2022 | 16:35

Medicamen Biotech Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Start SIP in MEDICAMEN BIOTECH

Start SIP

Medicamen Biotech Share Price

Medicamen Biotech Share Returns

  • Over 1 Month -8.67%
  • Over 3 Month -22.04%
  • Over 6 Month 21.34%
  • Over 1 Year 20.07%

Medicamen Biotech Key Statistics

P/E Ratio 77.7
PEG Ratio -8.8
Market Cap Cr 1,065
Price to Book Ratio 7.3
EPS 11.8
Dividend 0.1
Relative Strength Index 41.24
Money Flow Index 58.6
MACD Signal -18.36
Average True Range 36.47

Medicamen Biotech Investment Rating

  • Master Rating:
  • Medicamen Biotech has an operating revenue of Rs. 122.01 Cr. on a trailing 12-month basis. An annual revenue growth of 3% is not great, Pre-tax margin of 16% is great, ROE of 10% is good. The company has a reasonable debt to equity of 3%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its 50DMA and around 5% up from its 200DMA. It needs to take out the 50DMA levels and stay above it to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 54 which is a POOR score indicating inconsistency in earnings, a RS Rating of 46 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B which is evident from recent demand for the stock, Group Rank of 110 indicates it belongs to a poor industry group of Medical-Generic Drugs and a Master Score of C is fair but needs to improve. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Medicamen Biotech Financials
IndicatorSep 2022Jun 2022Mar 2022Dec 2021Sep 2021Jun 2021Mar 2021
Oper Rev Qtr Cr 34332333332820
Operating Expenses Qtr Cr 28271826262115
Operating Profit Qtr Cr 6656665
Depreciation Qtr Cr 2222110
Interest Qtr Cr 1110000
Tax Qtr Cr 1101111
Net Profit Qtr Cr 4434444

Medicamen Biotech Technicals

EMA & SMA

Current Price
841.8
9.4 (1.13%)
  • Bullish Moving Average
  • ___
  • 0
  • Bearish Moving Average
  • ___
  • 0
  • 20 Day
  • 862.84
  • 50 Day
  • 890.36
  • 100 Day
  • 877.26
  • 200 Day
  • 835.77
  • 20 Day
  • 859.73
  • 50 Day
  • 908.81
  • 100 Day
  • 902.45
  • 200 Day
  • 787.11

Medicamen Biotech Resistance and Support

PIVOT
₹836.54
Resistance
First Resistance 845.02
Second Resistance 857.64
Third Resistance 866.12
RSI 41.24
MFI 58.6
MACD Single Line -18.36
MACD -17.26
Support
First Resistance 823.92
Second Resistance 815.44
Third Resistance 802.82

Medicamen Biotech Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 4,992 343,699 68.85
Week 6,171 355,534 57.61
1 Month 10,273 607,848 59.17
6 Month 28,282 1,560,022 55.16

Medicamen Biotech Result Highlights

Medicamen Biotech Synopsis

NSE-Medical-Generic Drugs

Medicamen Biotec is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company’s Total Operating Revenue is Rs. 115.45 Cr. and Equity Capital is Rs. 12.22 Cr. for the Year ended 31/03/2022. Medicamen Biotech Ltd. is a Public Limited Listed company incorporated on 22/12/1993 and has its registered office in the State of Delhi, India. Company’s Corporate Identification Number(CIN) is L74899DL1993PLC056594 and registration number is 056594.
Market Cap 1,065
Sales 122
Shares in Float 0.72
No of funds 8
Yield 0.12
Book Value 6.87
U/D Vol ratio 0.4
LTDebt / Equity 3
Alpha 0.11
Beta 0.83

Medicamen Biotech

Owner NameSep-22Jun-22Mar-22Dec-21
Promoters 43.21%43.6%43.6%
Mutual Funds
Foreign Portfolio Investors 1.83%0.35%0.4%
Individual Investors 30.94%35.02%34.31%
Others 24.02%21.03%21.69%

Medicamen Biotech Management

Name Designation
Mr. Rahul Bishnoi Chairman
Dr. Vimal Kumar Shrawat Non Executive Director
Mr. Sanjay Bansal Non Executive Director
Mr. Suresh Kumar Singh Non Executive Director
Mr. Ashwani Kumar Sharma Non Executive Director
Ms. Sangeeta Bishnoi Independent Director
Dr. Ravi Kumar Bansal Independent Director
Mr. Harish Pande Independent Director
Mr. Arun Kumar Independent Director
Ms. Sumita Dwivedi Independent Director

Medicamen Biotech Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Medicamen Biotech Corporate Action

Date Purpose Remarks
2022-11-11 Quarterly Results
2022-08-10 Quarterly Results
2022-08-01 Preferential issue of shares
2022-05-25 Audited Results & Final Dividend
2022-02-08 Quarterly Results

Medicamen Biotech MF Shareholding

Name Amount(cr)
Motilal Oswal S&P BSE Healthcare ETF 6

Medicamen Biotech FAQs

What is Share Price of Medicamen Biotech ?

Medicamen Biotech share price is ₹841 As on 07 December, 2022 | 16:21

What is the Market Cap of Medicamen Biotech ?

The Market Cap of Medicamen Biotech is ₹1065 Cr As on 07 December, 2022 | 16:21

What is the P/E ratio of Medicamen Biotech ?

The P/E ratio of Medicamen Biotech is 77.7 As on 07 December, 2022 | 16:21

What is the PB ratio of Medicamen Biotech ?

The PB ratio of Medicamen Biotech is 7.3 As on 07 December, 2022 | 16:21

Q2FY23